Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Villarreal

12 clinical trials in Villarreal, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Villarreal at a glance
12
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

12 trials in Villarreal

Open in trial search

A study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Breast cancer

Recruiting

Comparing magnesium sulfate and dexmedetomidine combined with ropivacaine for pain relief after breast cancer surgery in women undergoing mastectomy

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dexmedetomidine
  • Sponsor:Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana

Study on the Effectiveness and Safety of Mannan-Conjugated Allergoids for Treating Allergic Rhinitis/Rhinoconjunctivitis in Patients Allergic to House Dust Mites

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dermatophagoides farinae enriched allergoid, mannan-conjugated, polymerised
  • Sponsor:Inmunotek S.L.

Perineal injury

Recruiting

Comparing Lidocaine-Prilocaine Cream and Lidocaine Injection for First-Degree Perineal Tear Repair in Women

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Lidocaine
  • Sponsor:Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana

Asthma

Recruiting

Study on Tezepelumab for Children Aged 5 to 11 with Severe Asthma

Registered drug
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Mite allergy

Recruiting

Study on the Effectiveness and Safety of Beltavac for Patients with Allergic Rhinitis from House Dust Mites

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Mixture Of Allergen Extracts Of Dermatophagoides Pteronyssinus And Dermatophagoides Farinae Polymerized With Glutaraldehyde
  • Sponsor:Probelte Pharma S.L.

Mite allergy

Not yet recruiting

Efficacy and safety of house dust mite allergoid (Dermatophagoides farinae, D. pteronyssinus, aluminium hydroxide) in people with moderate to severe house dust mite allergy

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Aluminium Hydroxide

Conjunctivitis allergic+1

Not yet recruiting

Diagnostic Accuracy of Parietaria judaica Pollen Extract (SPT‑RX) in a Skin Prick Test Drug Combination for Adults with Allergic Rhinitis and Controlled Mild Asthma

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Betula Pendula Pollen Extract
  • Sponsor:ROXALL Medizin GmbH

Study on Barzolvolimab for Patients with Chronic Spontaneous Urticaria Unresponsive to H1 Antihistamines

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.

Conjunctivitis allergic+1

Not recruiting

Study on the Safety and Effectiveness of Subcutaneous Immunotherapy with Der p 1, Der p 2, and Der p 23 Allergens for Patients with Allergic Rhinitis or Rhinoconjunctivitis

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dermatophagoides Pteronyssinus
  • Sponsor:Diater Laboratorio De Diagnostico Y Aplicaciones Terapeuticas S.A.

Asthma

Not recruiting

Study Comparing Depemokimab, Mepolizumab, and Benralizumab for Adults and Adolescents with Severe Eosinophilic Asthma

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:Glaxosmithkline Research & Development Limited

Asthma

Not recruiting

Study on the Effectiveness and Safety of Tanimilast for Patients with Uncontrolled Asthma on Inhaled Corticosteroid and Long-Acting Beta2-Agonist Therapy

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Tanimilast
  • Sponsor:Chiesi Farmaceutici S.p.A.

Other cities in Spain

The busiest research cities in the country

All 214 cities in Spain

Clinical research in Villarreal

What the registry says about research in the country

01 Respiratory Allergies Research

Several studies focus on developing innovative treatments for allergic rhinitis and rhinoconjunctivitis, particularly targeting reactions to house dust mites. These trials evaluate various immunotherapy approaches to improve patient outcomes.

  • House dust mite allergies
  • Immunotherapy effectiveness
  • Subcutaneous treatments

Research aims to enhance treatment options for patients with moderate to severe symptoms.

02 Severe Asthma Studies

Multiple clinical trials are investigating breakthrough treatments for severe uncontrolled asthma, including studies of new biological therapies and specialized medications for different age groups.

  • Pediatric asthma treatments
  • Biological therapies
  • Exacerbation reduction

Special focus on developing treatments for patients not responding to conventional therapies.

03 Dermatology & Pain Management

Research includes studies on chronic spontaneous urticaria and innovative approaches to pain management in medical procedures. These trials evaluate both systemic treatments and localized pain control methods.

  • Urticaria treatment
  • Pain control techniques
  • Anesthetic applications

Investigations aim to improve patient comfort and treatment effectiveness.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.